Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000134

Type of data
NGS (Target Capture)
69 genes・90 genes
Access criteria
Controlled-access (Type I)
Total data volume
19.7 GB
File formats
  • FASTQ
Research
hum0005
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000134 (opens in a new tab)
JGA Study
JGAS000123 (opens in a new tab)

Unrestricted-access files linked to this dataset

Download the URL list
FileLabelSizeCopy URL
cge12677-sup-0001-appendixs.pdf90 genes55.5 KB

Analysis method

Targeted DNA sequencing

Materials and participants
3 non-syndromic hearing loss patients (ICD10: H90)
  • Health status
    Affected
  • Subject count
    3 (Individual)
Disease
non-syndromic hearing loss patients (H90)
Sample description
gDNA extracted from peripheral blood cells
  • Tissue
    Peripheral blood
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
90 genes
(ACTG1, AIFM1, ALMS1, ATP2B2, CABP2, CACNA1D, CATSPER2,
CCDC50, CDH23, CEACAM16, CIB2, CLDN14, CLRN1, COCH,
COL11A2, CRYL1, CRYM, DFNA5, DIABLO, DIAPH1, DSPP, ESPN,
ESSRB, EYA1, EYA4, FOXI1, GIPC3, GJB2, GJB3, GJB6, GPR98,
GPSM2, GRHL2, GRXCR1, HGF, ILDR1, KCNJ10, KCNQ1, KCNQ4,
LHFPL5, LOXHD1, LRTOMT, MARVELD2, MSRB3, MYH14, MYH9,
MYO15A, MYO1A, MYO3A, MYO6, MYO7A, OTOA, OTOF, OTOG,
OTOGL, P2RX2, PCDH15, PDZD7, PJVK, PNPT1, POU3F4,
POU4F3, PRPS1, PTPRQ, RDX, SERPINB6, SIX1, SLC17A8,
SLC26A4, SLC26A5, SMPX, STRC, TECTA, TJP2, TMC1, TMIE,
TMPRSS3, TPRN, TRIOBP, TSPEAR, USH1C, USH1G, USH2A,
WFS1, WHRN, MIR96, MIR182, MIR183, MTRNR1, MTTS1)
Reagent kit
SureSelect XT Reagent Kit
Fragmentation
N/A
Platform
Illumina HiSeq 2000
Read type
Paired-end
Read length
100 bp
Phenotype data
Included
Data use policy
NBDC data sharing policy (JGAP000001)

Targeted DNA sequencing

Materials and participants
16 non-syndromic hearing loss patients (ICD10: H90)
  • Health status
    Affected
  • Subject count
    16 (Individual)
Disease
non-syndromic hearing loss patients (H90)
Sample description
gDNA extracted from peripheral blood cells
  • Tissue
    Peripheral blood
  • Tumor / normal
    Normal
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
69 genes
(ACTG1, CCDC50, CDH23, CEACAM16, CLDN14, COCH,
COL11A2, CRYM, DFNA5, DFNB59, DIAPH1, ESPN, ESRRB,
EYA4, GIPC3, GJB2, GJB3, GJB6, GPSM2, GRHL2, GRXCR1,
HGF, ILDR1, KCNQ4, LHFPL5, LOXHD1, LRTOMT, MARVELD2,
MIRN96, MSRB3, MYH14, MYH9, MYO15A, MYO1A, MYO3A,
MYO6, MYO7A, OTOA, OTOF, PCDH15, POU3F4, POU4F3,
PRPS1, PTPRQ, RDX, SERPINB6, SLC17A8, SLC26A4,
SLC26A5, SMAC, SMPX, STRC, TECTA, TJP2, TMC1, TMIE,
TMPRSS3, TPRN, TRIOBP, USH1C, USH2A, WFS1, WHRN)
Reagent kit
Ion AmpliSeq Custom Panel
Ion AmpliSeq Library Kit 2.0
Fragmentation
N/A
Platform
Thermo Fisher Scientific Ion PGM
Thermo Fisher Scientific Ion Proton
Read type
Single-end
Read length
200 bp
Data use policy
NBDC data sharing policy (JGAP000001)